question_id int64 337 65.5k | question stringlengths 11 209 | answer stringlengths 1 145 | document_text stringlengths 30 7.9k | page int64 1 1 | other_metadata dict | num_tokens int64 26 1.76k | match_type stringclasses 3
values | messages listlengths 2 2 |
|---|---|---|---|---|---|---|---|---|
64,080 | What is the status of the meeting "ASBMR"? | submitted | Page 1
Premarin Publication/Presentation Planning Meeting
April 12, 2000
10:30 AM - 12:00 PM, Conference Room #555-6A
AGENDA
I. Premarin Study Tracking Update
MEETINGS
Status
Meeting
Investigator
Study
Submitted
ASBMR
Lane
Estrogen and raloxifene on bone
microarchitecture
Ermer
TSE pharmacology
Presenting
First Interna... | 1 | {
"doc_id": 13253,
"image": "rpbw0217_1.png",
"ucsf_document_id": "rpbw0217",
"ucsf_document_page_no": "1"
} | 547 | exact | [
{
"content": "Document:\nPage 1\nPremarin Publication/Presentation Planning Meeting\nApril 12, 2000\n10:30 AM - 12:00 PM, Conference Room #555-6A\nAGENDA\nI. Premarin Study Tracking Update\nMEETINGS\nStatus\nMeeting\nInvestigator\nStudy\nSubmitted\nASBMR\nLane\nEstrogen and raloxifene on bone\nmicroarchitecture... |
64,081 | What is the status of the meeting "ACC"? | posters | Page 1
Premarin Publication/Presentation Planning Meeting
April 12, 2000
10:30 AM - 12:00 PM, Conference Room #555-6A
AGENDA
I. Premarin Study Tracking Update
MEETINGS
Status
Meeting
Investigator
Study
Submitted
ASBMR
Lane
Estrogen and raloxifene on bone
microarchitecture
Ermer
TSE pharmacology
Presenting
First Interna... | 1 | {
"doc_id": 13253,
"image": "rpbw0217_1.png",
"ucsf_document_id": "rpbw0217",
"ucsf_document_page_no": "1"
} | 546 | exact | [
{
"content": "Document:\nPage 1\nPremarin Publication/Presentation Planning Meeting\nApril 12, 2000\n10:30 AM - 12:00 PM, Conference Room #555-6A\nAGENDA\nI. Premarin Study Tracking Update\nMEETINGS\nStatus\nMeeting\nInvestigator\nStudy\nSubmitted\nASBMR\nLane\nEstrogen and raloxifene on bone\nmicroarchitecture... |
64,082 | What is the number of station progress notes? | 85 | Page 1
Station Progress
OCTOBER
Notes No. 85
1952
THE USE OF BYPRODUCTS OF
TERRITORIAL INDUSTRIES
IN SWINE RATIONS
by
0. Wayman and K. C. Leong
University of Hawaii
College of Agriculture
Agricultural Experiment Station
Honolulu, Hawaii
Source: https://www.industrydocuments.ucsf.edu/docs/xmy10226 | 1 | {
"doc_id": 13128,
"image": "xmyl0226_1.png",
"ucsf_document_id": "xmyl0226",
"ucsf_document_page_no": "1"
} | 107 | exact | [
{
"content": "Document:\nPage 1\nStation Progress\nOCTOBER\nNotes No. 85\n1952\nTHE USE OF BYPRODUCTS OF\nTERRITORIAL INDUSTRIES\nIN SWINE RATIONS\nby\n0. Wayman and K. C. Leong\nUniversity of Hawaii\nCollege of Agriculture\nAgricultural Experiment Station\nHonolulu, Hawaii\nSource: https://www.industrydocument... |
64,083 | What is the date mentioned in the document? | OCTOBER 1952 | Page 1
Station Progress
OCTOBER
Notes No. 85
1952
THE USE OF BYPRODUCTS OF
TERRITORIAL INDUSTRIES
IN SWINE RATIONS
by
0. Wayman and K. C. Leong
University of Hawaii
College of Agriculture
Agricultural Experiment Station
Honolulu, Hawaii
Source: https://www.industrydocuments.ucsf.edu/docs/xmy10226 | 1 | {
"doc_id": 13128,
"image": "xmyl0226_1.png",
"ucsf_document_id": "xmyl0226",
"ucsf_document_page_no": "1"
} | 113 | fuzzy | [
{
"content": "Document:\nPage 1\nStation Progress\nOCTOBER\nNotes No. 85\n1952\nTHE USE OF BYPRODUCTS OF\nTERRITORIAL INDUSTRIES\nIN SWINE RATIONS\nby\n0. Wayman and K. C. Leong\nUniversity of Hawaii\nCollege of Agriculture\nAgricultural Experiment Station\nHonolulu, Hawaii\nSource: https://www.industrydocument... |
64,086 | What is the page number? | 2 | Page 2
PROGRESS REPORT 11
Totelle Img
Client: Wyeth
er 18, 2002
PROJECT
CLASSIFICATION
TARGET
STATUS / ACTION
SUBMISSION
DATE /JOURNAL
Paper PS(3)
Hemostasis/metabolic impact
April 2003
Metabolic and hemostatic profile of
First draft submitted for initial review April 19th
postmenopausal women receiving a
Comments rece... | 1 | {
"doc_id": 13242,
"image": "zxbw0217_2.png",
"ucsf_document_id": "zxbw0217",
"ucsf_document_page_no": "2"
} | 596 | exact | [
{
"content": "Document:\nPage 2\nPROGRESS REPORT 11\nTotelle Img\nClient: Wyeth\ner 18, 2002\nPROJECT\nCLASSIFICATION\nTARGET\nSTATUS / ACTION\nSUBMISSION\nDATE /JOURNAL\nPaper PS(3)\nHemostasis/metabolic impact\nApril 2003\nMetabolic and hemostatic profile of\nFirst draft submitted for initial review April 19t... |
64,087 | What is the number of participants from the University of Minnesota? | 703 | Page 13
SUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING
JULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS
Number
Calendar Years Beginning
Participants
Center
1976
1977
1978
1979
1980
Randomized
University of Minnesota
618, 195
632, 114
636, 165
649, 379
649 , 042
703
Northwestern
74... | 1 | {
"doc_id": 9250,
"image": "gxxh0227_13.png",
"ucsf_document_id": "gxxh0227",
"ucsf_document_page_no": "13"
} | 380 | exact | [
{
"content": "Document:\nPage 13\nSUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING\nJULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS\nNumber\nCalendar Years Beginning\nParticipants\nCenter\n1976\n1977\n1978\n1979\n1980\nRandomized\nUniversity of Minnesota\n618, 195\n632, 114... |
64,089 | What is the number of participants from the University of Pittsburgh? | 645 | Page 13
SUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING
JULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS
Number
Calendar Years Beginning
Participants
Center
1976
1977
1978
1979
1980
Randomized
University of Minnesota
618, 195
632, 114
636, 165
649, 379
649 , 042
703
Northwestern
74... | 1 | {
"doc_id": 9250,
"image": "gxxh0227_13.png",
"ucsf_document_id": "gxxh0227",
"ucsf_document_page_no": "13"
} | 380 | exact | [
{
"content": "Document:\nPage 13\nSUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING\nJULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS\nNumber\nCalendar Years Beginning\nParticipants\nCenter\n1976\n1977\n1978\n1979\n1980\nRandomized\nUniversity of Minnesota\n618, 195\n632, 114... |
64,090 | What is the number of participants from the Cox Heart Institute? | 738 | Page 13
SUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING
JULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS
Number
Calendar Years Beginning
Participants
Center
1976
1977
1978
1979
1980
Randomized
University of Minnesota
618, 195
632, 114
636, 165
649, 379
649 , 042
703
Northwestern
74... | 1 | {
"doc_id": 9250,
"image": "gxxh0227_13.png",
"ucsf_document_id": "gxxh0227",
"ucsf_document_page_no": "13"
} | 380 | exact | [
{
"content": "Document:\nPage 13\nSUMMARY OF NEGOTIATED INCREMENTALLY FUNDED CONTRACTS BEGINNING\nJULY 1976 AND EXTENDING THROUGH JUNE 1980 AND TWO SINGLE YEAR CONTRACTS\nNumber\nCalendar Years Beginning\nParticipants\nCenter\n1976\n1977\n1978\n1979\n1980\nRandomized\nUniversity of Minnesota\n618, 195\n632, 114... |
64,093 | What is the total service in actual FTE 1981? | 22,723 | Page 1
VNA OF GREATER ST. LOUIS
PRODUCTIVITY REPORT
FOR THE MONTH OF SEPTEMBER, 1982
1981
1982
1982
VISIT BREAKDOWN PER
ACTUAL
ACTUAL
BUDGET
FULL TIME EQUIVALENT
FTE
FTE
FTE
1.
TOTAL VISITS
RN / LPN
12, 065
13, 251
11, 739
HHA
6, 413
7,131
6,908
Rehab
3, 358
3,393
2,953
Social Service
555
677
492
Consultant
332
379
268... | 1 | {
"doc_id": 9756,
"image": "sjcf0227_1.png",
"ucsf_document_id": "sjcf0227",
"ucsf_document_page_no": "1"
} | 641 | none | [
{
"content": "Document:\nPage 1\nVNA OF GREATER ST. LOUIS\nPRODUCTIVITY REPORT\nFOR THE MONTH OF SEPTEMBER, 1982\n1981\n1982\n1982\nVISIT BREAKDOWN PER\nACTUAL\nACTUAL\nBUDGET\nFULL TIME EQUIVALENT\nFTE\nFTE\nFTE\n1.\nTOTAL VISITS\nRN / LPN\n12, 065\n13, 251\n11, 739\nHHA\n6, 413\n7,131\n6,908\nRehab\n3, 358\n3... |
64,094 | What is the total FTE staff in 1982 actual FTE? | 411.3 | Page 1
VNA OF GREATER ST. LOUIS
PRODUCTIVITY REPORT
FOR THE MONTH OF SEPTEMBER, 1982
1981
1982
1982
VISIT BREAKDOWN PER
ACTUAL
ACTUAL
BUDGET
FULL TIME EQUIVALENT
FTE
FTE
FTE
1.
TOTAL VISITS
RN / LPN
12, 065
13, 251
11, 739
HHA
6, 413
7,131
6,908
Rehab
3, 358
3,393
2,953
Social Service
555
677
492
Consultant
332
379
268... | 1 | {
"doc_id": 9756,
"image": "sjcf0227_1.png",
"ucsf_document_id": "sjcf0227",
"ucsf_document_page_no": "1"
} | 643 | none | [
{
"content": "Document:\nPage 1\nVNA OF GREATER ST. LOUIS\nPRODUCTIVITY REPORT\nFOR THE MONTH OF SEPTEMBER, 1982\n1981\n1982\n1982\nVISIT BREAKDOWN PER\nACTUAL\nACTUAL\nBUDGET\nFULL TIME EQUIVALENT\nFTE\nFTE\nFTE\n1.\nTOTAL VISITS\nRN / LPN\n12, 065\n13, 251\n11, 739\nHHA\n6, 413\n7,131\n6,908\nRehab\n3, 358\n3... |
64,095 | Department of public health is in which division? | DIVISION OF RESEARCH | Page 6
Why are you interested in working in a state health department this summer?
Which programs or projects (if any) are of particular interest to you? (See Information for Applicants)
SIGNATURE OF APPLICANT
Applications should be returned to:
State of California
Department of Public Health
Division of Research
(Rev.... | 1 | {
"doc_id": 10058,
"image": "nycg0227_6.png",
"ucsf_document_id": "nycg0227",
"ucsf_document_page_no": "6"
} | 113 | exact | [
{
"content": "Document:\nPage 6\nWhy are you interested in working in a state health department this summer?\nWhich programs or projects (if any) are of particular interest to you? (See Information for Applicants)\nSIGNATURE OF APPLICANT\nApplications should be returned to:\nState of California\nDepartment of P... |
64,096 | What is the title of the document? | Table of Contents | Page 2
TABLE OF
CONTENTS
Page
Welcome To Our Cookbook. ..
When You Go Shopping. .
Flavor Adventures. .
Ingredient Substitutions....
Recipes and Cooking Tips
Entrees and Accompaniments . .
Sandwiches . .
Vegetables . . .
Salads and Salad Dressings.
Breads . . . . . . . .
Soups and Sauces. .
Desserts . . ..
Happy Snackin... | 1 | {
"doc_id": 9796,
"image": "sqmf0227_2.png",
"ucsf_document_id": "sqmf0227",
"ucsf_document_page_no": "2"
} | 236 | fuzzy | [
{
"content": "Document:\nPage 2\nTABLE OF\nCONTENTS\nPage\nWelcome To Our Cookbook. ..\nWhen You Go Shopping. .\nFlavor Adventures. .\nIngredient Substitutions....\nRecipes and Cooking Tips\nEntrees and Accompaniments . .\nSandwiches . .\nVegetables . . .\nSalads and Salad Dressings.\nBreads . . . . . . . .\nSo... |
64,097 | What is the first topic? | Welcome to our Cookbook | Page 2
TABLE OF
CONTENTS
Page
Welcome To Our Cookbook. ..
When You Go Shopping. .
Flavor Adventures. .
Ingredient Substitutions....
Recipes and Cooking Tips
Entrees and Accompaniments . .
Sandwiches . .
Vegetables . . .
Salads and Salad Dressings.
Breads . . . . . . . .
Soups and Sauces. .
Desserts . . ..
Happy Snackin... | 1 | {
"doc_id": 9796,
"image": "sqmf0227_2.png",
"ucsf_document_id": "sqmf0227",
"ucsf_document_page_no": "2"
} | 235 | exact | [
{
"content": "Document:\nPage 2\nTABLE OF\nCONTENTS\nPage\nWelcome To Our Cookbook. ..\nWhen You Go Shopping. .\nFlavor Adventures. .\nIngredient Substitutions....\nRecipes and Cooking Tips\nEntrees and Accompaniments . .\nSandwiches . .\nVegetables . . .\nSalads and Salad Dressings.\nBreads . . . . . . . .\nSo... |
64,098 | What is the second topic? | When you go Shopping | Page 2
TABLE OF
CONTENTS
Page
Welcome To Our Cookbook. ..
When You Go Shopping. .
Flavor Adventures. .
Ingredient Substitutions....
Recipes and Cooking Tips
Entrees and Accompaniments . .
Sandwiches . .
Vegetables . . .
Salads and Salad Dressings.
Breads . . . . . . . .
Soups and Sauces. .
Desserts . . ..
Happy Snackin... | 1 | {
"doc_id": 9796,
"image": "sqmf0227_2.png",
"ucsf_document_id": "sqmf0227",
"ucsf_document_page_no": "2"
} | 235 | exact | [
{
"content": "Document:\nPage 2\nTABLE OF\nCONTENTS\nPage\nWelcome To Our Cookbook. ..\nWhen You Go Shopping. .\nFlavor Adventures. .\nIngredient Substitutions....\nRecipes and Cooking Tips\nEntrees and Accompaniments . .\nSandwiches . .\nVegetables . . .\nSalads and Salad Dressings.\nBreads . . . . . . . .\nSo... |
64,099 | What is the third topic? | Flavor Adventures | Page 2
TABLE OF
CONTENTS
Page
Welcome To Our Cookbook. ..
When You Go Shopping. .
Flavor Adventures. .
Ingredient Substitutions....
Recipes and Cooking Tips
Entrees and Accompaniments . .
Sandwiches . .
Vegetables . . .
Salads and Salad Dressings.
Breads . . . . . . . .
Soups and Sauces. .
Desserts . . ..
Happy Snackin... | 1 | {
"doc_id": 9796,
"image": "sqmf0227_2.png",
"ucsf_document_id": "sqmf0227",
"ucsf_document_page_no": "2"
} | 234 | exact | [
{
"content": "Document:\nPage 2\nTABLE OF\nCONTENTS\nPage\nWelcome To Our Cookbook. ..\nWhen You Go Shopping. .\nFlavor Adventures. .\nIngredient Substitutions....\nRecipes and Cooking Tips\nEntrees and Accompaniments . .\nSandwiches . .\nVegetables . . .\nSalads and Salad Dressings.\nBreads . . . . . . . .\nSo... |
64,101 | What is the date mentioned at the bottom of the document? | 3/17/77 | Page 1
MISSOURI MEDICAID
Prior to September 1, 1974, the Visiting Nurse Association was paid as follows:
RN visit
$10. 00 - Both subject to a 12 visit maximum
LPN visit
8.00 in a 90 day period.
No other service covered.
Did not pay for supplies or equipment.
September 1, 1974 until November 23, 1976.
RN/LPN visit - our... | 1 | {
"doc_id": 9799,
"image": "yrvg0227_1.png",
"ucsf_document_id": "yrvg0227",
"ucsf_document_page_no": "1"
} | 390 | exact | [
{
"content": "Document:\nPage 1\nMISSOURI MEDICAID\nPrior to September 1, 1974, the Visiting Nurse Association was paid as follows:\nRN visit\n$10. 00 - Both subject to a 12 visit maximum\nLPN visit\n8.00 in a 90 day period.\nNo other service covered.\nDid not pay for supplies or equipment.\nSeptember 1, 1974 u... |
64,102 | What is the first date mentioned in the document? | September 1, 1974 | Page 1
MISSOURI MEDICAID
Prior to September 1, 1974, the Visiting Nurse Association was paid as follows:
RN visit
$10. 00 - Both subject to a 12 visit maximum
LPN visit
8.00 in a 90 day period.
No other service covered.
Did not pay for supplies or equipment.
September 1, 1974 until November 23, 1976.
RN/LPN visit - our... | 1 | {
"doc_id": 9799,
"image": "yrvg0227_1.png",
"ucsf_document_id": "yrvg0227",
"ucsf_document_page_no": "1"
} | 390 | exact | [
{
"content": "Document:\nPage 1\nMISSOURI MEDICAID\nPrior to September 1, 1974, the Visiting Nurse Association was paid as follows:\nRN visit\n$10. 00 - Both subject to a 12 visit maximum\nLPN visit\n8.00 in a 90 day period.\nNo other service covered.\nDid not pay for supplies or equipment.\nSeptember 1, 1974 u... |
64,103 | What is the title of the document? | Nutrition Research Alternatives | Page 2
Nutrition
Research
Alternatives
CONGRESS OF
THE UNITED STATES
Office of Technology Assessment
WASHINGTON. D. C. 20510
Source: https://www.industrydocuments.ucsf.edu/docs/rInf0227 | 1 | {
"doc_id": 9802,
"image": "rlnf0227_2.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "2"
} | 69 | fuzzy | [
{
"content": "Document:\nPage 2\nNutrition\nResearch\nAlternatives\nCONGRESS OF\nTHE UNITED STATES\nOffice of Technology Assessment\nWASHINGTON. D. C. 20510\nSource: https://www.industrydocuments.ucsf.edu/docs/rInf0227\n\nQuestion: What is the title of the document?",
"role": "user"
},
{
"content": ... |
64,104 | What is the full form of OTA? | Office of Technology Assessment | Page 2
Nutrition
Research
Alternatives
CONGRESS OF
THE UNITED STATES
Office of Technology Assessment
WASHINGTON. D. C. 20510
Source: https://www.industrydocuments.ucsf.edu/docs/rInf0227 | 1 | {
"doc_id": 9802,
"image": "rlnf0227_2.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "2"
} | 68 | exact | [
{
"content": "Document:\nPage 2\nNutrition\nResearch\nAlternatives\nCONGRESS OF\nTHE UNITED STATES\nOffice of Technology Assessment\nWASHINGTON. D. C. 20510\nSource: https://www.industrydocuments.ucsf.edu/docs/rInf0227\n\nQuestion: What is the full form of OTA?",
"role": "user"
},
{
"content": "Offi... |
64,105 | What is the table number? | 1 | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 258 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,106 | What is the full form of TA? | Titratable acid | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 263 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,107 | What is the age of the patient? | 37 Yr. | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 263 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,109 | What is the sex of the patient? | Male | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 260 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,110 | What is the pH of Arginine p.o.? | 6.31 | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 264 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,111 | What is the pH of Arginine-Glutamate p.o.? | 6.34 | Page 8
Effect of Arginine and Glutamic Acid
on Urinary Electrolyte Excretion
Patient G Male, 37 Yr.
STUDY PERIOD
URINARY EXCRETIONS - mEq/day
T.A.
NHa
Net it
DH
Control
23
33
56
67
5.71
Arginine p.0.
0
29
29
90
6.31
Control
23
37
57
Glutamic Acid p.o.
37
60
5.53
22
59
72
17
75
5.70
Control
33
50
5.97
Arginine-Glutamate... | 1 | {
"doc_id": 9803,
"image": "xglg0227_8.png",
"ucsf_document_id": "xglg0227",
"ucsf_document_page_no": "8"
} | 267 | exact | [
{
"content": "Document:\nPage 8\nEffect of Arginine and Glutamic Acid\non Urinary Electrolyte Excretion\nPatient G Male, 37 Yr.\nSTUDY PERIOD\nURINARY EXCRETIONS - mEq/day\nT.A.\nNHa\nNet it\nDH\nControl\n23\n33\n56\n67\n5.71\nArginine p.0.\n0\n29\n29\n90\n6.31\nControl\n23\n37\n57\nGlutamic Acid p.o.\n37\n60\n... |
64,112 | What is the name of the person? | Irene Karl | Page 1
Name
Title
Amount
Dates
02 28 46148 IRENE KARL
22 3235 11 00 64117 Res. Assit
500.00 100.00 3510 2/1/63 * 2/28/63"
18. 13
500.00
18 . 13 | 1 | {
"doc_id": 9814,
"image": "xklg0227_1.png",
"ucsf_document_id": "xklg0227",
"ucsf_document_page_no": "1"
} | 94 | exact | [
{
"content": "Document:\nPage 1\nName\nTitle\nAmount\nDates\n02 28 46148 IRENE KARL\n22 3235 11 00 64117 Res. Assit\n500.00 100.00 3510 2/1/63 * 2/28/63\"\n18. 13\n500.00\n18 . 13\n\nQuestion: What is the name of the person?",
"role": "user"
},
{
"content": "Irene Karl",
"role": "assistant"
}
... |
64,113 | What is the title? | Res. Ass't | Page 1
Name
Title
Amount
Dates
02 28 46148 IRENE KARL
22 3235 11 00 64117 Res. Assit
500.00 100.00 3510 2/1/63 * 2/28/63"
18. 13
500.00
18 . 13 | 1 | {
"doc_id": 9814,
"image": "xklg0227_1.png",
"ucsf_document_id": "xklg0227",
"ucsf_document_page_no": "1"
} | 92 | fuzzy | [
{
"content": "Document:\nPage 1\nName\nTitle\nAmount\nDates\n02 28 46148 IRENE KARL\n22 3235 11 00 64117 Res. Assit\n500.00 100.00 3510 2/1/63 * 2/28/63\"\n18. 13\n500.00\n18 . 13\n\nQuestion: What is the title?",
"role": "user"
},
{
"content": "Res. Ass't",
"role": "assistant"
}
] |
64,114 | What is the amount? | 500.00 | Page 1
Name
Title
Amount
Dates
02 28 46148 IRENE KARL
22 3235 11 00 64117 Res. Assit
500.00 100.00 3510 2/1/63 * 2/28/63"
18. 13
500.00
18 . 13 | 1 | {
"doc_id": 9814,
"image": "xklg0227_1.png",
"ucsf_document_id": "xklg0227",
"ucsf_document_page_no": "1"
} | 91 | exact | [
{
"content": "Document:\nPage 1\nName\nTitle\nAmount\nDates\n02 28 46148 IRENE KARL\n22 3235 11 00 64117 Res. Assit\n500.00 100.00 3510 2/1/63 * 2/28/63\"\n18. 13\n500.00\n18 . 13\n\nQuestion: What is the amount?",
"role": "user"
},
{
"content": "500.00",
"role": "assistant"
}
] |
64,115 | What is the first title in the document? | Chapter IV | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 62 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: What is the first title in the document?",
"role": "user"
},
{
"content": "Chapter IV",
"role": "assis... |
64,116 | What is the second title in the document? | Congressional Options | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 63 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: What is the second title in the document?",
"role": "user"
},
{
"content": "Congressional Options",
"r... |
64,117 | The first image represents which nutrient? | Vitamins | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 61 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: The first image represents which nutrient?",
"role": "user"
},
{
"content": "Vitamins",
"role": "assis... |
64,118 | The second image represents which nutrient? | fats | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 60 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: The second image represents which nutrient?",
"role": "user"
},
{
"content": "fats",
"role": "assistan... |
64,119 | The third image represents which nutrient? | minerals | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 60 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: The third image represents which nutrient?",
"role": "user"
},
{
"content": "minerals",
"role": "assis... |
64,120 | The fourth image represents which nutrient? | carbohydrates | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 61 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: The fourth image represents which nutrient?",
"role": "user"
},
{
"content": "carbohydrates",
"role": ... |
64,121 | The fifth image represents which nutrient? | proteins | Page 43
Chapter IV
CONGRESSIONAL OPTIONS
vitamins
fats
minerals
carbohydrates
proteins
Source: https://www.industrydocuments.ucsf.edu/docs/rinf0227 | 1 | {
"doc_id": 9819,
"image": "rlnf0227_43.png",
"ucsf_document_id": "rlnf0227",
"ucsf_document_page_no": "43"
} | 61 | exact | [
{
"content": "Document:\nPage 43\nChapter IV\nCONGRESSIONAL OPTIONS\nvitamins\nfats\nminerals\ncarbohydrates\nproteins\nSource: https://www.industrydocuments.ucsf.edu/docs/rinf0227\n\nQuestion: The fifth image represents which nutrient?",
"role": "user"
},
{
"content": "proteins",
"role": "assis... |
64,122 | What is the page number? | 2 | Page 2
SODIUM & POTASSIUM
Page 2
over-all muscle weakness poor intestinal tone with distension, cardiac
weakness, weakness of the respiratory muscles and their eventual failure (12, 13).
Darrow (14 ) has emphasized the importance of the potassium deficiency syndromes
associated with infectious diarrhea in infants and i... | 1 | {
"doc_id": 9823,
"image": "xtpg0227_2.png",
"ucsf_document_id": "xtpg0227",
"ucsf_document_page_no": "2"
} | 532 | exact | [
{
"content": "Document:\nPage 2\nSODIUM & POTASSIUM\nPage 2\nover-all muscle weakness poor intestinal tone with distension, cardiac\nweakness, weakness of the respiratory muscles and their eventual failure (12, 13).\nDarrow (14 ) has emphasized the importance of the potassium deficiency syndromes\nassociated wi... |
64,123 | What is the table number? | 1 | Page 8
Table 1
Effect of menadione and casein diets on the prothrombin
time of K-deficient chicks1
Diet
Supplement
Prothrombin
time2
sec .
Soya protein
200 +
Soya protein
0.01 Ka3 Y/gm diet
146 + 3.35
Soya protein
0.1 Ka Y/gm diet
25 + 1.7
Casein (Labco ) 4
33 + 2.9
Casein (NBC)
46 + 4.0
1 Chicks were maintained on the... | 1 | {
"doc_id": 9826,
"image": "xtkg0227_8.png",
"ucsf_document_id": "xtkg0227",
"ucsf_document_page_no": "8"
} | 259 | exact | [
{
"content": "Document:\nPage 8\nTable 1\nEffect of menadione and casein diets on the prothrombin\ntime of K-deficient chicks1\nDiet\nSupplement\nProthrombin\ntime2\nsec .\nSoya protein\n200 +\nSoya protein\n0.01 Ka3 Y/gm diet\n146 + 3.35\nSoya protein\n0.1 Ka Y/gm diet\n25 + 1.7\nCasein (Labco ) 4\n33 + 2.9\nC... |
64,124 | What is the title of the first column of the table? | Diet | Page 8
Table 1
Effect of menadione and casein diets on the prothrombin
time of K-deficient chicks1
Diet
Supplement
Prothrombin
time2
sec .
Soya protein
200 +
Soya protein
0.01 Ka3 Y/gm diet
146 + 3.35
Soya protein
0.1 Ka Y/gm diet
25 + 1.7
Casein (Labco ) 4
33 + 2.9
Casein (NBC)
46 + 4.0
1 Chicks were maintained on the... | 1 | {
"doc_id": 9826,
"image": "xtkg0227_8.png",
"ucsf_document_id": "xtkg0227",
"ucsf_document_page_no": "8"
} | 266 | exact | [
{
"content": "Document:\nPage 8\nTable 1\nEffect of menadione and casein diets on the prothrombin\ntime of K-deficient chicks1\nDiet\nSupplement\nProthrombin\ntime2\nsec .\nSoya protein\n200 +\nSoya protein\n0.01 Ka3 Y/gm diet\n146 + 3.35\nSoya protein\n0.1 Ka Y/gm diet\n25 + 1.7\nCasein (Labco ) 4\n33 + 2.9\nC... |
64,125 | What is the title of the second column of the table? | Supplement | Page 8
Table 1
Effect of menadione and casein diets on the prothrombin
time of K-deficient chicks1
Diet
Supplement
Prothrombin
time2
sec .
Soya protein
200 +
Soya protein
0.01 Ka3 Y/gm diet
146 + 3.35
Soya protein
0.1 Ka Y/gm diet
25 + 1.7
Casein (Labco ) 4
33 + 2.9
Casein (NBC)
46 + 4.0
1 Chicks were maintained on the... | 1 | {
"doc_id": 9826,
"image": "xtkg0227_8.png",
"ucsf_document_id": "xtkg0227",
"ucsf_document_page_no": "8"
} | 266 | exact | [
{
"content": "Document:\nPage 8\nTable 1\nEffect of menadione and casein diets on the prothrombin\ntime of K-deficient chicks1\nDiet\nSupplement\nProthrombin\ntime2\nsec .\nSoya protein\n200 +\nSoya protein\n0.01 Ka3 Y/gm diet\n146 + 3.35\nSoya protein\n0.1 Ka Y/gm diet\n25 + 1.7\nCasein (Labco ) 4\n33 + 2.9\nC... |
64,127 | Who is the account executive? | Clare Cheng | Page 1
& MANN, INC.
450 Lexington Avenue,
New York NY 1001
CLINE
DAVIS
212 907 4800
July 16, 1996
Dr. Michael Merren
CONFIDENTIAL
8042 Wurzbach, #640
San Antonio, TX
78229
Dear Dr. Merren,
Thank you for agreeing to speak at the Epilepsy Advisory Meeting to be held
in Atlanta from August 2 to August 4, 1996. A revised a... | 1 | {
"doc_id": 10148,
"image": "qzmd0217_1.png",
"ucsf_document_id": "qzmd0217",
"ucsf_document_page_no": "1"
} | 273 | exact | [
{
"content": "Document:\nPage 1\n& MANN, INC.\n450 Lexington Avenue,\nNew York NY 1001\nCLINE\nDAVIS\n212 907 4800\nJuly 16, 1996\nDr. Michael Merren\nCONFIDENTIAL\n8042 Wurzbach, #640\nSan Antonio, TX\n78229\nDear Dr. Merren,\nThank you for agreeing to speak at the Epilepsy Advisory Meeting to be held\nin Atla... |
64,128 | What is the name of the location? | Monte Carlo Room A | Page 1
& MANN, INC.
450 Lexington Avenue,
New York NY 1001
CLINE
DAVIS
212 907 4800
July 16, 1996
Dr. Michael Merren
CONFIDENTIAL
8042 Wurzbach, #640
San Antonio, TX
78229
Dear Dr. Merren,
Thank you for agreeing to speak at the Epilepsy Advisory Meeting to be held
in Atlanta from August 2 to August 4, 1996. A revised a... | 1 | {
"doc_id": 10148,
"image": "qzmd0217_1.png",
"ucsf_document_id": "qzmd0217",
"ucsf_document_page_no": "1"
} | 277 | exact | [
{
"content": "Document:\nPage 1\n& MANN, INC.\n450 Lexington Avenue,\nNew York NY 1001\nCLINE\nDAVIS\n212 907 4800\nJuly 16, 1996\nDr. Michael Merren\nCONFIDENTIAL\n8042 Wurzbach, #640\nSan Antonio, TX\n78229\nDear Dr. Merren,\nThank you for agreeing to speak at the Epilepsy Advisory Meeting to be held\nin Atla... |
64,130 | What is the length? | Approximately 30 minutes | Page 1
& MANN, INC.
450 Lexington Avenue,
New York NY 1001
CLINE
DAVIS
212 907 4800
July 16, 1996
Dr. Michael Merren
CONFIDENTIAL
8042 Wurzbach, #640
San Antonio, TX
78229
Dear Dr. Merren,
Thank you for agreeing to speak at the Epilepsy Advisory Meeting to be held
in Atlanta from August 2 to August 4, 1996. A revised a... | 1 | {
"doc_id": 10148,
"image": "qzmd0217_1.png",
"ucsf_document_id": "qzmd0217",
"ucsf_document_page_no": "1"
} | 274 | exact | [
{
"content": "Document:\nPage 1\n& MANN, INC.\n450 Lexington Avenue,\nNew York NY 1001\nCLINE\nDAVIS\n212 907 4800\nJuly 16, 1996\nDr. Michael Merren\nCONFIDENTIAL\n8042 Wurzbach, #640\nSan Antonio, TX\n78229\nDear Dr. Merren,\nThank you for agreeing to speak at the Epilepsy Advisory Meeting to be held\nin Atla... |
64,132 | What is the second title in the document? | PAPERS FOR WMC SYMPOSIUM PROCEEDINGS | Page 2
PROGRESS REPORT 11
Totelle Img
Client: Wyeth
er 18, 2002
PROJECT
CLASSIFICATION
TARGET
STATUS / ACTION
SUBMISSION
DATE /JOURNAL
Paper PS(3)
Hemostasis/metabolic impact
April 2003
Metabolic and hemostatic profile of
First draft submitted for initial review April 19th
postmenopausal women receiving a
Comments rece... | 1 | {
"doc_id": 13242,
"image": "zxbw0217_2.png",
"ucsf_document_id": "zxbw0217",
"ucsf_document_page_no": "2"
} | 612 | exact | [
{
"content": "Document:\nPage 2\nPROGRESS REPORT 11\nTotelle Img\nClient: Wyeth\ner 18, 2002\nPROJECT\nCLASSIFICATION\nTARGET\nSTATUS / ACTION\nSUBMISSION\nDATE /JOURNAL\nPaper PS(3)\nHemostasis/metabolic impact\nApril 2003\nMetabolic and hemostatic profile of\nFirst draft submitted for initial review April 19t... |
64,173 | Mention item "c" which may be included in making salads? | head lettuce with dressing | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 430 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,174 | Mention item "e" which may be included in making salads? | cabbage slaw | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 430 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,175 | Mention item "d" which may be included in making salads? | sliced tomatoes on lettuce | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 431 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,176 | Mention item "g" which may be included in making salads? | tomato aspic | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 430 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,177 | "These salads must be substituted for" what "at a meal"? | one vegetable | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 429 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,182 | Which dessert name is given as "A" under "10"? | lemon jelly | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 430 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,186 | Which dessert name is given as "B" under "10"? | lemon snow | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 429 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,194 | Provide the reference number given at right bottom corner of the page? | 2/49 DH-236.5 | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 435 | fuzzy | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,196 | Dessert recipe for how many servings is given? | SIX SERVINGS | Page 5
9 .
Salads may include the following:
a.
Grapefruit slices ( unsweetened) on lettuce leaves with dressing.
b .
Tossed salad of lettuce, tomatoes, carrots, radishes, green
peppers .
C .
Head lettuce with dressing.
d.
Sliced tomatoes on lettuce.
e .
Cabbage slaw.
Jellied vegetable salad (unflavored gelatine with c... | 1 | {
"doc_id": 9648,
"image": "mswg0227_5.png",
"ucsf_document_id": "mswg0227",
"ucsf_document_page_no": "5"
} | 429 | exact | [
{
"content": "Document:\nPage 5\n9 .\nSalads may include the following:\na.\nGrapefruit slices ( unsweetened) on lettuce leaves with dressing.\nb .\nTossed salad of lettuce, tomatoes, carrots, radishes, green\npeppers .\nC .\nHead lettuce with dressing.\nd.\nSliced tomatoes on lettuce.\ne .\nCabbage slaw.\nJell... |
64,240 | What type of profiles is shown in the table ? | Critical Congress Profiles | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 710 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,242 | What is the first Column heading given? | Specialty | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 707 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,300 | Whose responsibility is to provide the correct information? | Author's | Page 48
3 To be filled in if the copyright does not belong to you
Please provide the complete and full title of the copyright holder. This will be printed on the copyright line on
each page of the article. It is the author's responsibility to provide the correct information.
(a)
Name and address of copyright holder (if... | 1 | {
"doc_id": 10156,
"image": "fmjm0223_48.png",
"ucsf_document_id": "fmjm0223",
"ucsf_document_page_no": "48"
} | 219 | exact | [
{
"content": "Document:\nPage 48\n3 To be filled in if the copyright does not belong to you\nPlease provide the complete and full title of the copyright holder. This will be printed on the copyright line on\neach page of the article. It is the author's responsibility to provide the correct information.\n(a)\nNa... |
64,301 | Who grants Blackwell Science Ltd non-exclusive rights to deal with requests from third parties? | The copyright holder | Page 48
3 To be filled in if the copyright does not belong to you
Please provide the complete and full title of the copyright holder. This will be printed on the copyright line on
each page of the article. It is the author's responsibility to provide the correct information.
(a)
Name and address of copyright holder (if... | 1 | {
"doc_id": 10156,
"image": "fmjm0223_48.png",
"ucsf_document_id": "fmjm0223",
"ucsf_document_page_no": "48"
} | 227 | exact | [
{
"content": "Document:\nPage 48\n3 To be filled in if the copyright does not belong to you\nPlease provide the complete and full title of the copyright holder. This will be printed on the copyright line on\neach page of the article. It is the author's responsibility to provide the correct information.\n(a)\nNa... |
64,318 | The Invitation Was Made By A? | Firm other than Pharmaceutical Company | Page 2
EVENT 1:" Page 2 93
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmacoutical Company Associated With The Event
Yes Company Name: Parke Dau
192
City/State:
O No
Event Date (MominDayNew): OR LOSE2.
The Invitation Was Made By A:
Were CME Credits Of... | 1 | {
"doc_id": 10191,
"image": "rjmd0217_2.png",
"ucsf_document_id": "rjmd0217",
"ucsf_document_page_no": "2"
} | 586 | exact | [
{
"content": "Document:\nPage 2\nEVENT 1:\" Page 2 93\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmacoutical Company Associated With The Event\nYes Company Name: Parke Dau\n192\nCity/State:\nO No\nEvent Date (MominDayNew): OR LOSE2.\nThe I... |
64,330 | was a pharmaceutical company associated with the event? | Yes | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 581 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,333 | what is the hotel name? | Airport Marriott | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 579 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,335 | what is the city/state? | SF, CA | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 580 | fuzzy | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,337 | were CME credits offered? | Yes | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 578 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,338 | what type of Honorarlum was offered? | Meals | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 582 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,340 | what is the event number? | 1 | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 578 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,341 | what is the page number mentioned? | Page 1 of 3 | Page 2
EVENT1: Page 1 of 3
PRI-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmaceutical Company Associated With The Event?
A Yes Company Name:
125
City/State:
SF Ca
602484
O No
Event Date ( North Dayroar): 1 $1298
The Invitation Was Made By A:
Were CME Cre... | 1 | {
"doc_id": 10199,
"image": "qlmd0217_2.png",
"ucsf_document_id": "qlmd0217",
"ucsf_document_page_no": "2"
} | 584 | exact | [
{
"content": "Document:\nPage 2\nEVENT1: Page 1 of 3\nPRI-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmaceutical Company Associated With The Event?\nA Yes Company Name:\n125\nCity/State:\nSF Ca\n602484\nO No\nEvent Date ( North Dayroar): 1 $129... |
64,345 | what is the status of study # 945-420-010? | In progress | Page 53
Neurontin Study Report
Studies Sorted by Study Type and Status
Budget
Date
Date
Date
Type/
Study
Start Completion
Amount Budget
First
Last
Study #
Study Title
Status
Funder
Champion Investigators Country (ies) Date
Dat
Dates
Approved Approved
Check
Check Notes/Comments
945-420-010
Neuropathic pain cancer
In Pro... | 1 | {
"doc_id": 10219,
"image": "jnjm0223_53.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "53"
} | 492 | exact | [
{
"content": "Document:\nPage 53\nNeurontin Study Report\nStudies Sorted by Study Type and Status\nBudget\nDate\nDate\nDate\nType/\nStudy\nStart Completion\nAmount Budget\nFirst\nLast\nStudy #\nStudy Title\nStatus\nFunder\nChampion Investigators Country (ies) Date\nDat\nDates\nApproved Approved\nCheck\nCheck No... |
64,346 | when was the london meeting held? | 13-Aug-01 | Page 53
Neurontin Study Report
Studies Sorted by Study Type and Status
Budget
Date
Date
Date
Type/
Study
Start Completion
Amount Budget
First
Last
Study #
Study Title
Status
Funder
Champion Investigators Country (ies) Date
Dat
Dates
Approved Approved
Check
Check Notes/Comments
945-420-010
Neuropathic pain cancer
In Pro... | 1 | {
"doc_id": 10219,
"image": "jnjm0223_53.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "53"
} | 487 | exact | [
{
"content": "Document:\nPage 53\nNeurontin Study Report\nStudies Sorted by Study Type and Status\nBudget\nDate\nDate\nDate\nType/\nStudy\nStart Completion\nAmount Budget\nFirst\nLast\nStudy #\nStudy Title\nStatus\nFunder\nChampion Investigators Country (ies) Date\nDat\nDates\nApproved Approved\nCheck\nCheck No... |
64,347 | What is the Event Date? | 02/09/98 | Page 2
EVENT 1:" Page 2 93
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmacoutical Company Associated With The Event
Yes Company Name: Parke Dau
192
City/State:
O No
Event Date (MominDayNew): OR LOSE2.
The Invitation Was Made By A:
Were CME Credits Of... | 1 | {
"doc_id": 10191,
"image": "rjmd0217_2.png",
"ucsf_document_id": "rjmd0217",
"ucsf_document_page_no": "2"
} | 584 | none | [
{
"content": "Document:\nPage 2\nEVENT 1:\" Page 2 93\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmacoutical Company Associated With The Event\nYes Company Name: Parke Dau\n192\nCity/State:\nO No\nEvent Date (MominDayNew): OR LOSE2.\nThe I... |
64,348 | what is the type/funder for study # 945-278? | Drug only | Page 53
Neurontin Study Report
Studies Sorted by Study Type and Status
Budget
Date
Date
Date
Type/
Study
Start Completion
Amount Budget
First
Last
Study #
Study Title
Status
Funder
Champion Investigators Country (ies) Date
Dat
Dates
Approved Approved
Check
Check Notes/Comments
945-420-010
Neuropathic pain cancer
In Pro... | 1 | {
"doc_id": 10219,
"image": "jnjm0223_53.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "53"
} | 492 | exact | [
{
"content": "Document:\nPage 53\nNeurontin Study Report\nStudies Sorted by Study Type and Status\nBudget\nDate\nDate\nDate\nType/\nStudy\nStart Completion\nAmount Budget\nFirst\nLast\nStudy #\nStudy Title\nStatus\nFunder\nChampion Investigators Country (ies) Date\nDat\nDates\nApproved Approved\nCheck\nCheck No... |
64,349 | what country is mentioned for study # 945-278? | UK | Page 53
Neurontin Study Report
Studies Sorted by Study Type and Status
Budget
Date
Date
Date
Type/
Study
Start Completion
Amount Budget
First
Last
Study #
Study Title
Status
Funder
Champion Investigators Country (ies) Date
Dat
Dates
Approved Approved
Check
Check Notes/Comments
945-420-010
Neuropathic pain cancer
In Pro... | 1 | {
"doc_id": 10219,
"image": "jnjm0223_53.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "53"
} | 489 | exact | [
{
"content": "Document:\nPage 53\nNeurontin Study Report\nStudies Sorted by Study Type and Status\nBudget\nDate\nDate\nDate\nType/\nStudy\nStart Completion\nAmount Budget\nFirst\nLast\nStudy #\nStudy Title\nStatus\nFunder\nChampion Investigators Country (ies) Date\nDat\nDates\nApproved Approved\nCheck\nCheck No... |
64,350 | Were CME Credits Offered? | No | Page 2
EVENT 1:" Page 2 93
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you attended.
Was A Pharmacoutical Company Associated With The Event
Yes Company Name: Parke Dau
192
City/State:
O No
Event Date (MominDayNew): OR LOSE2.
The Invitation Was Made By A:
Were CME Credits Of... | 1 | {
"doc_id": 10191,
"image": "rjmd0217_2.png",
"ucsf_document_id": "rjmd0217",
"ucsf_document_page_no": "2"
} | 581 | exact | [
{
"content": "Document:\nPage 2\nEVENT 1:\" Page 2 93\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you attended.\nWas A Pharmacoutical Company Associated With The Event\nYes Company Name: Parke Dau\n192\nCity/State:\nO No\nEvent Date (MominDayNew): OR LOSE2.\nThe I... |
64,353 | what is the date mentioned at the bottom of the document? | 31-Oct-01 | Page 53
Neurontin Study Report
Studies Sorted by Study Type and Status
Budget
Date
Date
Date
Type/
Study
Start Completion
Amount Budget
First
Last
Study #
Study Title
Status
Funder
Champion Investigators Country (ies) Date
Dat
Dates
Approved Approved
Check
Check Notes/Comments
945-420-010
Neuropathic pain cancer
In Pro... | 1 | {
"doc_id": 10219,
"image": "jnjm0223_53.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "53"
} | 492 | exact | [
{
"content": "Document:\nPage 53\nNeurontin Study Report\nStudies Sorted by Study Type and Status\nBudget\nDate\nDate\nDate\nType/\nStudy\nStart Completion\nAmount Budget\nFirst\nLast\nStudy #\nStudy Title\nStatus\nFunder\nChampion Investigators Country (ies) Date\nDat\nDates\nApproved Approved\nCheck\nCheck No... |
64,354 | what is the event number? | 2 | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 546 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,358 | approximately how many physicians attended the event? | 10 | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 548 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,359 | what is the number of speakers? | 1 | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 547 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,360 | what is the length of the event? | 1 hr | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 549 | fuzzy | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,362 | was a pharmaceutical representative present? | No | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 546 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,365 | what is the rating given for usefulness of the information recieved at the event? | 6 | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 555 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,367 | what event factors had the greatest impact on overall event rating? | Speaker quality | Page 3
EVENT 2: Page 3 of 3
The presentation was conducted by: (Check all that apply)
How useful did you find the information you received at the event?
Drug company representative
Local physician/researcher (specify name): Y- The crag ALD,
Not useful
1 2 3 4 5 67
Extremely useful
Visiting physician/researcher (specify... | 1 | {
"doc_id": 10220,
"image": "qnmd0217_3.png",
"ucsf_document_id": "qnmd0217",
"ucsf_document_page_no": "3"
} | 553 | exact | [
{
"content": "Document:\nPage 3\nEVENT 2: Page 3 of 3\nThe presentation was conducted by: (Check all that apply)\nHow useful did you find the information you received at the event?\nDrug company representative\nLocal physician/researcher (specify name): Y- The crag ALD,\nNot useful\n1 2 3 4 5 67\nExtremely usef... |
64,368 | what is the number mentioned at the top right corner? | 602425 | Page 2
EVENT 1: Page 1 of 3
602425
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you allended.
Was A Pharmaceutical Company Associated With The Event?
City/State:_
Fennville, MI
Yes Company Name: Parke - Davis
192
O No
Event Date ( ManinDayroar): 1) 1 1 9 2
The Invitation Was... | 1 | {
"doc_id": 10233,
"image": "hjmd0217_2.png",
"ucsf_document_id": "hjmd0217",
"ucsf_document_page_no": "2"
} | 603 | exact | [
{
"content": "Document:\nPage 2\nEVENT 1: Page 1 of 3\n602425\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you allended.\nWas A Pharmaceutical Company Associated With The Event?\nCity/State:_\nFennville, MI\nYes Company Name: Parke - Davis\n192\nO No\nEvent Date ( ... |
64,370 | What is the pharmaceuticals company name? | Parke Davis | Page 2
EVENT 1: Page 1 of 3
602425
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you allended.
Was A Pharmaceutical Company Associated With The Event?
City/State:_
Fennville, MI
Yes Company Name: Parke - Davis
192
O No
Event Date ( ManinDayroar): 1) 1 1 9 2
The Invitation Was... | 1 | {
"doc_id": 10233,
"image": "hjmd0217_2.png",
"ucsf_document_id": "hjmd0217",
"ucsf_document_page_no": "2"
} | 601 | fuzzy | [
{
"content": "Document:\nPage 2\nEVENT 1: Page 1 of 3\n602425\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you allended.\nWas A Pharmaceutical Company Associated With The Event?\nCity/State:_\nFennville, MI\nYes Company Name: Parke - Davis\n192\nO No\nEvent Date ( ... |
64,373 | what is th event date? | 11/4/97 | Page 2
EVENT 1: Page 1 of 3
602425
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you allended.
Was A Pharmaceutical Company Associated With The Event?
City/State:_
Fennville, MI
Yes Company Name: Parke - Davis
192
O No
Event Date ( ManinDayroar): 1) 1 1 9 2
The Invitation Was... | 1 | {
"doc_id": 10233,
"image": "hjmd0217_2.png",
"ucsf_document_id": "hjmd0217",
"ucsf_document_page_no": "2"
} | 601 | none | [
{
"content": "Document:\nPage 2\nEVENT 1: Page 1 of 3\n602425\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you allended.\nWas A Pharmaceutical Company Associated With The Event?\nCity/State:_\nFennville, MI\nYes Company Name: Parke - Davis\n192\nO No\nEvent Date ( ... |
64,375 | were CME credits offered? | No | Page 2
EVENT 1: Page 1 of 3
602425
PRE-EVENT INFORMATION
Please complete these questions for all invitations, whether or not you allended.
Was A Pharmaceutical Company Associated With The Event?
City/State:_
Fennville, MI
Yes Company Name: Parke - Davis
192
O No
Event Date ( ManinDayroar): 1) 1 1 9 2
The Invitation Was... | 1 | {
"doc_id": 10233,
"image": "hjmd0217_2.png",
"ucsf_document_id": "hjmd0217",
"ucsf_document_page_no": "2"
} | 597 | exact | [
{
"content": "Document:\nPage 2\nEVENT 1: Page 1 of 3\n602425\nPRE-EVENT INFORMATION\nPlease complete these questions for all invitations, whether or not you allended.\nWas A Pharmaceutical Company Associated With The Event?\nCity/State:_\nFennville, MI\nYes Company Name: Parke - Davis\n192\nO No\nEvent Date ( ... |
64,392 | were specific products discussed? | Yes | Page 3
EVENT 1: Page 2 of 3
PRODUCT INFORMATION
Woro Specific Products Discussed?
Yes (Please complete the boxes in this section.)
How many times
O No (Please go to the "General Theme"
have you been
box at the bottom of this page.)
detailed on this
At what level do
At what level do
product in the last you currently Rx
... | 1 | {
"doc_id": 10260,
"image": "jmmd0217_3.png",
"ucsf_document_id": "jmmd0217",
"ucsf_document_page_no": "3"
} | 253 | exact | [
{
"content": "Document:\nPage 3\nEVENT 1: Page 2 of 3\nPRODUCT INFORMATION\nWoro Specific Products Discussed?\nYes (Please complete the boxes in this section.)\nHow many times\nO No (Please go to the \"General Theme\"\nhave you been\nbox at the bottom of this page.)\ndetailed on this\nAt what level do\nAt what ... |
64,394 | what is the phase number? | 17 | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 346 | exact | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,399 | what is the practice speciality? | IM | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 347 | exact | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,401 | what is the number of active studies? | 1 | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 348 | exact | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,402 | who approves study budget? | Himself | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 347 | none | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,404 | where are study records and study drugs stored? | locked cabinet | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 350 | fuzzy | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,410 | what is the number of newly diagonised? | 15/month | Page 17
diabetics .
minsites
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
DIDB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Richard De Amics, MD
Address:
Courthase
land
... | 1 | {
"doc_id": 10264,
"image": "gxyd0217_17.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "17"
} | 350 | none | [
{
"content": "Document:\nPage 17\ndiabetics .\nminsites\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nDIDB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's Name:\nRi... |
64,415 | what is the practice speciality? | Lipids | Page 3
women
minorities
diabetics
(2)
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
ITB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Gary Balady, MD
Address:
Phone:
(617 ... | 1 | {
"doc_id": 10265,
"image": "gxyd0217_3.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "3"
} | 326 | exact | [
{
"content": "Document:\nPage 3\nwomen\nminorities\ndiabetics\n(2)\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nITB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's... |
64,418 | what is the number of newly diagonised? | 10/month | Page 3
women
minorities
diabetics
(2)
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
ITB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Gary Balady, MD
Address:
Phone:
(617 ... | 1 | {
"doc_id": 10265,
"image": "gxyd0217_3.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "3"
} | 327 | none | [
{
"content": "Document:\nPage 3\nwomen\nminorities\ndiabetics\n(2)\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nITB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's... |
64,419 | where are the study records and study drugs stored? | locked cabinet | Page 3
women
minorities
diabetics
(2)
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
ITB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Gary Balady, MD
Address:
Phone:
(617 ... | 1 | {
"doc_id": 10265,
"image": "gxyd0217_3.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "3"
} | 328 | fuzzy | [
{
"content": "Document:\nPage 3\nwomen\nminorities\ndiabetics\n(2)\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nITB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's... |
64,421 | when is the local IRB meeting scheduled? | once/month | Page 3
women
minorities
diabetics
(2)
SITE SELECTION CRITERIA FOR Atorvastatin
PHASE
ITB/TV INVESTIGATORS
THIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS
YOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH
PHASE IIIB/TV TROGLITAZONE PROGRAMS.
Doctor's Name:
Gary Balady, MD
Address:
Phone:
(617 ... | 1 | {
"doc_id": 10265,
"image": "gxyd0217_3.png",
"ucsf_document_id": "gxyd0217",
"ucsf_document_page_no": "3"
} | 327 | none | [
{
"content": "Document:\nPage 3\nwomen\nminorities\ndiabetics\n(2)\nSITE SELECTION CRITERIA FOR Atorvastatin\nPHASE\nITB/TV INVESTIGATORS\nTHIS FORM IS TO BE COMPLETED IN ITS ENTIRITY FOR THOSE PHYSICIANS\nYOU WOULD LIKE TO HAVE CONSIDERED FOR THE MEDICAL RESEARCH\nPHASE IIIB/TV TROGLITAZONE PROGRAMS.\nDoctor's... |
64,442 | Mention the "website" given for "Collegium Internationale Neuro-Psychopharmacologicum" Congress? | www.cinp.org | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 725 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,443 | Mention the "Acronym" given for "Collegium Internationale Neuro-Psychopharmacologicum" Congress? | CINP | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 725 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,444 | Mention the "Total Attend." given for "Collegium Internationale Neuro-Psychopharmacologicum" Congress? | 5,000 | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 725 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,445 | Mention the "Total Prof. Attend." given for "Collegium Internationale Neuro-Psychopharmacologicum" Congress? | 5,000 | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 727 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,446 | Mention the "Acronym" given for "International Congress of Neuropsychiatry"? | ICN | Page 109
Neurontin
Critical Congress Profiles
Congresses, Sorted by Congress Specialty and Title
Satellite
Total
Abstracts
Symposia
Geographic
Total
Prof.
Specialty
Congress
Acronym
Accepted Permitted |Exhibits
Target Audience
%
Audienc
% Attend. Attend.
Web site
Collegium Internationale Neuro-
CINP
Yes
Yes
Yes
Psychia... | 1 | {
"doc_id": 10175,
"image": "jnjm0223_109.png",
"ucsf_document_id": "jnjm0223",
"ucsf_document_page_no": "109"
} | 716 | exact | [
{
"content": "Document:\nPage 109\nNeurontin\nCritical Congress Profiles\nCongresses, Sorted by Congress Specialty and Title\nSatellite\nTotal\nAbstracts\nSymposia\nGeographic\nTotal\nProf.\nSpecialty\nCongress\nAcronym\nAccepted Permitted |Exhibits\nTarget Audience\n%\nAudienc\n% Attend. Attend.\nWeb site\nCol... |
64,447 | "Art will be out of town until" which day? | Thursday | Page 1
Mr. Place:
Art will be out of town until Thursday, I
learned today when I called for an answer to your letter.
I did not mail your letter (although I like the
way you stated your case and your attitude to the board)
as I was not sure whether or not you wanted to wait for
Art's possible criticism of your letter.
... | 1 | {
"doc_id": 10297,
"image": "khgl0226_1.png",
"ucsf_document_id": "khgl0226",
"ucsf_document_page_no": "1"
} | 116 | exact | [
{
"content": "Document:\nPage 1\nMr. Place:\nArt will be out of town until Thursday, I\nlearned today when I called for an answer to your letter.\nI did not mail your letter (although I like the\nway you stated your case and your attitude to the board)\nas I was not sure whether or not you wanted to wait for\nA... |
64,448 | Who wrote the letter? | CJB | Page 1
Mr. Place:
Art will be out of town until Thursday, I
learned today when I called for an answer to your letter.
I did not mail your letter (although I like the
way you stated your case and your attitude to the board)
as I was not sure whether or not you wanted to wait for
Art's possible criticism of your letter.
... | 1 | {
"doc_id": 10297,
"image": "khgl0226_1.png",
"ucsf_document_id": "khgl0226",
"ucsf_document_page_no": "1"
} | 110 | exact | [
{
"content": "Document:\nPage 1\nMr. Place:\nArt will be out of town until Thursday, I\nlearned today when I called for an answer to your letter.\nI did not mail your letter (although I like the\nway you stated your case and your attitude to the board)\nas I was not sure whether or not you wanted to wait for\nA... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.